low dose glp-1 for inflammation Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications The anti-inflammatory feature of glucagon-like

Although the direct inhibition of DPP-4 activity does not seem to regulate bone remodeling, the impact of DPP-4 on bone metabolism is indirect, involving the modulation of DPP-4 substrates and inflammation within the bone microenvironment

The safety of DPP-4 inhibitor and SGLT2 inhibitor combination therapies

Moreover, in addition to the direct action of GIP in adipose tissue to reduce serum triglyceride levels, GLP-1 may abolish the postprandial rise in triglyceride and free fatty acid concentrations by reducing intestinal absorption of dietary lipid, stemmed from the delayed gastric emptying (197, 198)

3 In fact, the effects of GIPR activation on glycemia and body weight have been controversial

GLP-1 and dual agonists: Insulin needs can fall quickly (often around 30% early on), and bolus timing may need adjustment due to slower gastric emptying

Add a fiber supplement if bowel movements are less than daily